2-Amino-3,7-dimethylimidazo[4,5-f]quinoxaline

Suppliers

Names

[ CAS No. ]:
78411-56-0

[ Name ]:
2-Amino-3,7-dimethylimidazo[4,5-f]quinoxaline

[Synonym ]:
2-Amino-3,7-dimethylimidazo(4,5-f)quinoxaline
2-amino-3,7-dimethylimidazo<quinoxaline
1H-Imidazo(4,5-f)quinoxaline,2-amino-3,7-dimethyl
7-Methyl-IQX
3,7-dimethyl-3H-imidazo<4,5-f>quinoxalin-2-amine

Chemical & Physical Properties

[ Density]:
1.47g/cm3

[ Boiling Point ]:
458.4ºC at 760 mmHg

[ Molecular Formula ]:
C11H11N5

[ Molecular Weight ]:
213.23900

[ Flash Point ]:
231ºC

[ Exact Mass ]:
213.10100

[ PSA ]:
69.62000

[ LogP ]:
1.98830

[ Index of Refraction ]:
1.776

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ5925400
CHEMICAL NAME :
1H-Imidazo(4,5-f)quinoxaline, 2-amino-3,7-dimethyl-
CAS REGISTRY NUMBER :
78411-56-0
LAST UPDATED :
199410
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C11-H12-N5
MOLECULAR WEIGHT :
214.28

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

TYPE OF TEST :
Mutation in microorganisms
TEST SYSTEM :
Bacteria - Salmonella typhimurium
DOSE/DURATION :
2 ng/plate
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 144,131,1985

Safety Information

[ HS Code ]:
2933990090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • N-benzyl-3,7-dimethylimidazo[4,5-f]quinoxalin-2-amine
  • 2-bromo-3,7-dimethylimidazo[4,5-f]quinoxaline
  • 3,7-dimethyl-2-methylsulfanylimidazo[4,5-f]quinoxaline
  • 3,7-dimethyl-2-methylsulfonylimidazo[4,5-f]quinoxaline
  • 4-Fluoro-2-nitroaniline
  • 3,4-diamino-1-fluorobenzene
  • Cyanogen bromide
  • 2-methyl-5-nitroquinoxalin-6-amine
  • 1,2-Diamino-4-nitrobenzene

DownStream

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Related Compounds

  • 2-AMINO-3,5-DIMETHYLIMIDAZO(4,5-F)QUINOXALINE
  • 2-bromo-3,7-dimethylimidazo[4,5-f]quinoxaline
  • 2-AMINO-3,7,8-TRIMETHYL-3H-IMIDAZO[4,5-F]QUINOXALINE
  • N-hydroxy-2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline
  • N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
  • N(2)-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline 3',5'-diphosphate
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
  • N-[3-(Aminooxy)propyl]-N-butyl-1-butanamine